Altimmune, Inc. (ALT)
NASDAQ · Healthcare
Altimmune, Inc. Total Liabilities 2010–2025
Altimmune, Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Altimmune, Inc. total liabilities as of December 31, 2025: 55.0M, a 248.38% increase year-over-year.
- Altimmune, Inc. total liabilities for 2025 were 55.0M, a 248.38% increase from 2024.
- Altimmune, Inc. total liabilities for 2024 were 15.8M, a 4.49% decrease from 2023.
- Altimmune, Inc. total liabilities for 2023 were 16.5M, a 23.55% decrease from 2022.
- Altimmune, Inc. total liabilities for 2022 were 21.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Altimmune, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $55 |
| 2024 | $16 |
| 2023 | $17 |
| 2022 | $22 |
| 2021 | $20 |
| 2020 | $19 |
| 2019 | $9 |
| 2018 | $6 |
| 2017 | $14 |
| 2016 | $6 |
| 2011 | $7 |
| 2010 | $15 |
Altimmune, Inc. Total Liabilities — FAQ
Altimmune, Inc. (ALT) total liabilities over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALT's total liabilities history?
The chart and table above show Altimmune, Inc.'s total liabilities by year and by quarter, including the growth rate.